logo
NasdaqCM:DCTH logo

Delcath Systems Community

NasdaqCM:DCTH Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

DCTH logo
Delcath Systems
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

HEPZATO Launch And European Expansion Will Expand Treatment Access

Key Takeaways Expansion in U.S. treatment centers and commercial teams is expected to drive significant revenue growth and improve operational efficiencies. European market strategy and new R&D initiatives could lead to strategic revenue growth and future innovations.
View narrative
US$22.50
FV
44.9% undervalued intrinsic discount
60.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative